Inmed pharmaceuticals to report full year fiscal 2021 financial results and business update on september 24, 2021

Vancouver, british columbia, sept. 17, 2021 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a leader in the manufacturing and clinical development of rare cannabinoids, will report financial results for the fiscal year ended june 30, 2021, on friday, september 24, 2021.

INM Ratings Summary

INM Quant Ranking